Frage | Antworten |
Trade names | Lanoxin - Sigmaxin |
Therapeutic class | Antiarrythmic |
Pharmaceutical class | glycoside |
Indications | treatment and management of: - congestive cardiac insufficiency - Arrhythmias - heart failure. |
Action | Inhibits sodium/potassium transporting pump leading to an increase in intracellular sodium -> this increases the amount of calcium pumped into the cardiac muscle, increasing contractility of the heart. |
Therapeutic effect | Pumping action of the heart is improved - by increasing diastolic fill time. |
Absorption | 70 - 80 % absorbed in small intestine |
Distribution | extensively distributed across tissues -> rapidly crosses placenta and enters breastmilk |
Metabolism & excretion | Majority is excreted unchanged in urine |
half-life | 36 hours |
Contraindicators/precautions | Caution use in the elderly Hyperthyroidism - may decrease concentration Hypothyroidism - may increase concentration Acute MI Heart blocks Renal impairment |
Adverse reactions | CVS: May worsen arrhythmias, bradycardia CNS: headache, drowsiness GIT: N + V OPTHAL: may cause blurred yellow/green vision |
Interactions | May increase the effect of other drugs that slow cardiac conduction |
nursing assessment impications | Monitor HR (< 60 withold) Check renal functioning and electrolytes before admin Cardiovascular assess |
Education points | Teach patient how to monitor pulse Ask them to stick to 1 brand |
Möchten Sie mit GoConqr kostenlos Ihre eigenen Karteikarten erstellen? Mehr erfahren.